Charity Accounts Intelreading the accounts so you don’t have to

CYSTIC FIBROSIS TRUST — grant history

Registered charity 1079049 · filings on the Charity Commission register

Latest income
£12.0m
Grants listed (FY2025)
40
Listed grants total
£12.1m
Accounts grants total
£1.4m

listed grants do not fully reconcile with the accounts total — list may be partialextracted from its FY2025 accounts

What this funder supports

Based on the register classifications and operating areas of the grant recipients we could match to the charity register (a subset of all grantees).

Causes funded
  • Education/training (2 grantees)
  • The Advancement Of Health Or Saving Of Lives (2 grantees)
  • Disability (1 grantee)
Where grantees operate
  • Throughout England And Wales (2 grantees)
  • Northern Ireland (1 grantee)
  • Scotland (1 grantee)

Grants made, per its accounts filings

Download this grant history as CSV (open data, provenance and licence noted in the file).

RecipientYearAmountPurpose
University of CambridgeFY2025£800kSRC028 - Developing better treatments for Mycobacterium abscessus
University of NewcastleFY2025£800kSRC026 - PTSuppress – Novel lead compounds as potential suppressor drugs for CFTR PTC mutations
Royal Brompton HospitalFY2025£799kSRC027 - MATRIARCH_CF – MATeRnal, InfAnt, Reproductive and Child Health in CF
St James’ HospitalFY2025£750kSRC012 - The Impact of Gut Dysbiosis on Lung Inflammation in cystic fibrosis
Imperial College LondonFY2025£750kSRC014 - Personalised Approach to Pseudomonas Aeruginosa (PAPA)
Imperial College LondonFY2025£750kSRC015 - TrIFIC: Targeting Immunotherapy for Fungal Infections in cystic fibrosis
University of NewcastleFY2025£750kSRC019 - Mechanisms and measures of the pathways through which cystic fibrosis exocrine pancreatic disease leads to beta-cell dysfunction and diabetes
University of Nottingham / Queens University BelfastFY2025£750kSRC023 - Gut Research Advancing a Mechanistic and Personalised Understanding of Symptoms in cystic fibrosis: A strategic research centre: The GRAMPUS-CF SRC
University of SheffieldFY2025£749kSRC018 - Preventing gastrointestinal cancer in cystic fibrosis
University of BristolFY2025£748kSRC021 - The CFTR Folding and Function SRC
University of CambridgeFY2025£744kSRC016 - Mucociliary clearance – from fundamentals to personalised treatment
University College LondonFY2025£375kSRC020 - Therapeutic gene editing of CFTR. Co-funded with CFF
University College LondonFY2025£375kSRC024 - Restoring the fizz: Pharmacological repair of bicarbonate transport in cystic fibrosis. Co-funded with CFF
University of LiverpoolFY2025£375kSRC022 - An evidence-based preclinical framework for the development of antimicrobial therapeutics in cystic fibrosis (PIPE-CF). Co-funded with CFF
University of SheffieldFY2025£367kSRC025 - Pulmonary magnetic resonance imaging for cystic fibrosis. Co-funded with CFF
University of BirminghamFY2025£300kDA003 - Developing autologous stem cell-derived therapies for cystic fibrosis diabetes
Royal Brompton HospitalFY2025£300kDA001 - ADVANCE-CFTR: Advanced Diagnostic Validation and Novel Clinical Evaluation across the CFTR spectrum
Newcastle UniversityFY2025£275kDA004 - Novel role for succinate chemosensing in the pathogenesis of CF airway disease
University of LiverpoolFY2025£173kDA002 - ITCH-CF: Investigating The Cardiovascular Health of people living with cystic fibrosis
Imperial College LondonFY2025£100kVIA116 - Repurposing the multiple sclerosis drug, Glatiramer acetate, to potentiate the action of conventional antibiotics for cystic fibrosis airway infections
Action Medical ResearchFY2025£100kVIA132 - New therapeutic approaches for treating cystic fibrosis
Our Lady's Children's HospitalFY2025£96kVIA118 - ENHANCE – Establishing Natural History in an Advanced New CF Care Era
University of NottinghamFY2025£93kVIA105 - Core Outcome Set Taskforce for Cystic Fibrosis (COST-CF): a patient-initiated core outcome set for CF
University of CambridgeFY2025£75kVIA130 - AIR max: 3D AIRway organoids to define and MAXimize the efficacy of CFTR gene therapy
Utrecht University, NetherlandsFY2025£75kVIA123 - Understanding hypo- and hyper-responding phenotypes of CFTR mutants for therapeutic use
University of CambridgeFY2025£65kVIA128 - Investigating the impact of pathoadaptive mutations on the fitness of Pseudomonas aeruginosa in a polymicrobial airway environment.
University of CambridgeFY2025£59kVIA133 - Characterising the host-pathogen interactions required for intracellular Pseudomonas aeruginosa infection of people with cystic fibrosis
Northumbria UniversityFY2025£55kVIA129 - Impact of respiratory infection antibiotics upon the gut microbiomes of children with CF
Ockham Biotech LtdFY2025£50kVIA117 - Investigating anti-pseudomonal effects of roneparstat, a non-anticoagulant derivative of heparin with multiple anti-microbial, anti-inflammatory and mucolytic activities
University of NottinghamFY2025£50kVIA062 - Scholarship for the National Biofilms Innovation Centre (NBIC)
Newcastle UniversityFY2025£50kVIA127 - Tracking the mucosal immune response to viral respiratory tract infection in children with cystic fibrosis
University College LondonFY2025£50kVIA119 - Understanding Regional Lung Physiology in Cystic Fibrosis Using Advanced MRI
Imperial College LondonFY2025£43kVIA036 - PhD studentship 2 – Air pollution and environmental factors on infection – linking with Registry data
University of NottinghamFY2025£38kVIA107 - Development of a rapid and highly sensitive analytical method for the detection of biomarkers of infection in samples from people with CF
Aston UniversityFY2025£25kVIA098 - Discovery of new and repurposed ß-lactamase inhibitors for improving Mycobacterium abscessus treatment
Bowel Research UKFY2025£25kVIA131 - Optimising bowel cancer screening and surveillance for people with cystic fibrosis: a qualitative study to identify and understand clinician and patient challenges and needs and ways to address these
OmniSpirant LimitedFY2025£21kVIA124 - Cell engineering optimisation and electrophysiology assessment of OS001 CFTR Extracellular Vesicles (EVs)
Leeds Beckett UniversityFY2025£21kVIA126 - Cancer risk, screening, and surveillance for people with cystic fibrosis: a national co-designed survey of awareness, perceptions, and behaviours, and information and support needs
London School of Hygiene and Tropical MedicineFY2025£18kVIA121 - Target trial emulation in cystic fibrosis: optimising methods for evaluating long term antibiotic treatment using registry data
University of LiverpoolFY2025£17kVIA115 - Postal Sputum Testing for Early Detection of Pseudomonas aeruginosa in CF: POSTED-CF
University of CambridgeFY2024£1.2mResearch / Innovation Hub
Imperial College London / Royal Brompton HospitalFY2024£1.1mResearch
Newcastle UniversityFY2024£850kResearch
CTAP centresFY2024£436kTrial Coordinator commitments made to CTAP centres
Various CF centresFY2024£326kRegistry support grants
University of LiverpoolFY2024£182kResearch
Action Medical ResearchFY2024£105kResearch
Medical Research CouncilFY2024£100kResearch
Innovation Hub CambridgeFY2024£100kResearch
Utrecht University, NetherlandsFY2024£75kResearch
Other Institutions (less than £20k)FY2024£68kResearch
UCLFY2024£50kResearch
Medicines Discovery Catapult LimitedFY2024£42kResearch
Leeds Beckett UniversityFY2024£21kResearch
OmniSpirant LimitedFY2024£21kResearch
Queen’s University BelfastFY2024£8kResearch
Trial Coordinator commitments made to CTAP centresFY2023£953kClinical Care
University of LiverpoolFY2023£753kResearch
Registry support grants made to various CF centresFY2023£609kClinical Care
Innovation Hub CambridgeFY2023£241kResearch
UCL Great Ormond StreetFY2023£121kResearch
Cystic Fibrosis Canada (Fibrose Kystique) CFCFY2023£116kResearch
University of NottinghamFY2023£115kResearch
Royal College of Surgeons in IrelandFY2023£96kResearch
Medicines Discovery Catapult LimitedFY2023£81kResearch
Medical Research CouncilFY2023£50kResearch
Newcastle UniversityFY2023£50kResearch
University Hospital LlandoughFY2023£46kResearch
Aston UniversityFY2023£28kResearch
Queen’s University BelfastFY2023£26kResearch
MDC (CF AMR Syndicate)FY2023£20kResearch
Ockham Biotech LimitedFY2023£17kResearch
Various CF centresFY2022£1.6mRegistry support grants
Innovation Hub CambridgeFY2022£1.5mResearch grant to University of Cambridge
University of NottinghamFY2022£880kResearch grant
University of LiverpoolFY2022£769kResearch grant
UCL Great Ormond StreetFY2022£750kResearch grant
University of BristolFY2022£749kResearch grant
CTAP centresFY2022£685kTrial Coordinator commitments
University of CambridgeFY2022£365kResearch grant
Queen Elizabeth University HospitalFY2022£180kResearch grant
Cystic Fibrosis Canada (Fibrose Kystique) CFCFY2022£141kResearch grant
RNIDFY2022£120kResearch grant
Diabetes UKFY2022£105kResearch grant
MDC (CF AMR Syndicate)FY2022£95kResearch grant
Imperial College London / Royal Brompton HospitalFY2022£70kResearch grant
University of EdinburghFY2022£70kResearch grant
Belfast City HospitalFY2022£50kResearch grant
Medicines Discovery CatapultFY2022£50kResearch grant
University Hospital LlandoughFY2022£45kResearch grant
Other Insititutions (less than £20k)FY2022£39kResearch grants
Newcastle UniversityFY2022£37kResearch grant
University of CopenhagenFY2022£27kResearch grant
Aston UniversityFY2022£25kResearch grant
The University of ManchesterFY2022£23kResearch grant
Queen’s University BelfastFY2022£21kResearch grant

About this data

This grant list is extracted by automated reading of the grant-maker’s own accounts PDFs as filed with the Charity Commission, and cross-checked against the accounts’ stated grant totals (listed sum 12054907 vs reference 1379000 (774.2% diff; ref=stated)). Recipients are linked to register entries only on an exact charity-number or unambiguous exact-name match. If you represent this funder and want a correction, contact us.